RXi Pharmaceuticals Corporation (RXII) slipped -12.45% or -0.28 to $2.0. It is near 454545 shares traded, which is 138.78% compare to the average total volume 327540. The market cap of RXII is $8.53 million. The year to date change is -58.36%. The 52 week price range is from $2.0 to $7.7. Price of RXII have changed -11.24% during last week. It have changed -23.41% over last month, -30.61% over last 3 months, -59.78% over last 6 months and -58.37% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for RXII is 3.19. It is 59.50% above current price. The 200-day Moving Averages for RXII is 4.73. It is 136.50% above current price. The 52-week High is 7.7. It is 285.00% from the current price. The 52-week Low is 2.0. The stock hits 52-week low today.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of RXII is 0.61 on 2018-04-13. Short % to float is 10.87%. There are some statistics of RXII. It is has market cap $8.53 million. The share outstanding is 4.26 million. The average volume is 327540. The percent of top 15 Institution holding is 32.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of RXII is -244.28%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of RXII is -128.50%.